Screener
Assembly Biosciences ASMB Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accrued research and development expenses | 1,538 | 2,387 |
| Other accrued expenses | 2,664 | 7,749 |
| Deferred revenue from a related party | 29,076 | 36,904 |
| Operating lease liabilities - short-term | 590 | 569 |
| Total current liabilities | 34,997 | 48,780 |
| Operating lease liabilities - long-term | 1,901 | 2,059 |
| Total liabilities | 36,898 | 50,839 |
| Commitments and contingencies |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's operating lease liabilities (current)?
- Assembly Biosciences (ASMB) reported operating lease liabilities (current) of $590K in Q1 2026.
- How has Assembly Biosciences's operating lease liabilities (current) changed year-over-year?
- Assembly Biosciences's operating lease liabilities (current) increased by 11.5% year-over-year, from $529K to $590K.
- What is the long-term trend for Assembly Biosciences's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Assembly Biosciences's operating lease liabilities (current) has grown at a -30.1% compound annual growth rate (CAGR), from $3.4M to $569K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Assembly Biosciences's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude